Zhen Xia has more than ten years of experiences in downstream process development, tech transfer, and scale-up of biomacromolecules. Currently she focuses on the late stage development of downstream process, including process characterization, validation, change control and other related work. She is experienced in multi-country BLA filling for antibody drugs.
